Community Parner Event: Your Health is Personal - hosted by GABA

Personalized Medicine for Diagnostic and Therapy Personalized medicine revolutionizes healthcare by tailoring treatment to each individual's unique genetic makeup, lifestyle, and environment. By analyzing a patient's genetic markers, doctors can predict disease susceptibility, select the most effective therapies, and minimize side effects. Treatments like those used for breast cancer that target the human epidermal growth factor receptor 2 (HER2) or tests that look at specific markers in tumors to diagnose cancer are examples of personalized medicine in action. It shifts healthcare from a one-size-fits-all model to precise, targeted interventions, improving outcomes and quality of life for patients in a cost-effective way.

Personalized medicine is poised to shape the future of healthcare. In 2023, the U.S. market was worth about $168.45 billion. Experts predict it could grow to nearly $373.96 billion by 2033, with an annual growth rate of 8.5% from 2024 to 2033.

Speakers:
Katja Hanack, PhD Founder and CEO new/era/mabs
Sudha Krishnan, PhD VP of Business Development, Abzena
J. Dianne Keen-Kim, PhD SVP, Laboratory Affairs and Quality, CLIA Director, Natera
Merrit Savener, Biotech Commercial Strategist Business Strategy Consultant, Merrit Science
Dr. Thomas Koehnke, Instructor, Institute for Stem Cell Biology and Regenerative Medicine, Stanford University.